Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children

Fertility and Sterility

Volumn 87, Issue 4, 2007, Pages 896-901

  Kalfa, Nicolas ^a,b   Philibert, Pascal ^a   Patte, Catherine ^c   Ecochard, Aude ^a   Duvillard, Pierre ^c   Baldet, Pierre ^d   Jaubert, Francis ^e   Fellous, Marc ^b   Sultan, Charles ^a,b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b INSERM   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d LAPEYRONIE HOSPITAL   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

child; granulosa cell tumor; human FOXL2 protein; Ovarian neoplasms; prognosis

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; ARTICLE; ASCITES; CANCER STAGING; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRANULOSA CELL TUMOR; GRANULOSA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 34147185809     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.016     Document Type: Article

References (38)

1. Young R.H., and Scully R.E. Endocrine tumors of the ovary. Curr Top Pathol 85 (1992) 113-164
2. Scully R.E. Ovarian tumors with endocrine manifestations. In: DeGroot L.J. (Ed). Endocrinology (1995), Saunders, Philadelphia 2113-2139
3. Young R.H., Dickersin G.R., and Scully R.E. Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol 8 (1984) 575-596
4. Kalfa N., Patte C., Orbach D., Lecointre C., Pienkowski C., Philippe F., et al. A nationwide study of granulosa cell tumors in pre- and postpubertal girls: missed diagnosis of endocrine manifestations worsens prognosis. J Pediatr Endocrinol Metab 18 (2005) 25-31
5. Fuller P.J., Verity K., Shen Y., Mamers P., Jobling T., and Burger H.G. No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors. J Clin Endocrinol Metab 83 (1998) 274-279
6. Graves P.E., Surwit E.A., Davis J.R., and Stouffer R.L. Adenylate cyclase in human ovarian cancers: sensitivity to gonadotropins and nonhormonal activators. Am J Obstet Gynecol 153 (1985) 877-882
7. Fuller P.J., Chu S., Jobling T., Mamers P., Healy D.L., and Burger H.G. Inhibin subunit gene expression in ovarian cancer. Gynecol Oncol 73 (1999) 273-279
8. Amsterdam A., and Selvaraj N. Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocr Rev 18 (1997) 435-461
9. Prueitt R.L., and Zinn A.R. A fork in the road to fertility. Nat Genet 27 (2001) 132-134
10. Cocquet J., De Baere E., Gareil M., Pannetier M., Xia X., Fellous M., et al. Structure, evolution and expression of the FOXL2 transcription unit. Cytogenet Genome Res 101 (2003) 206-211
11. Cocquet J., Pailhoux E., Jaubert F., Servel N., Xia X., Pannetier M., et al. Evolution and expression of FOXL2. J Med Genet 39 (2002) 916-921
12. Govoroun M.S., Pannetier M., Pailhoux E., Cocquet J., Brillard J.P., Couty I., et al. Isolation of chicken homolog of the FOXL2 gene and comparison of its expression patterns with those of aromatase during ovarian development. Dev Dyn 231 (2004) 859-870
13. Schmidt D., Ovitt C.E., Anlag K., Fehsenfeld S., Gredsted L., Treier A.C., et al. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131 (2004) 933-942
14. Uda M., Ottolenghi C., Crisponi L., Garcia J.E., Deiana M., Kimber W., et al. Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 13 (2004) 1171-1181
15. Benedet J.L., Bender H., Jones III H., Ngan H.Y., Pecorelli S., and FIGO Committee on Gynecologic Oncology. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int J Gynaecol Obstet 70 (2000) 209-262
16. Tanner J.M., and Whitehouse R.H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51 (1976) 170-179
17. Coppes M.J., Ye Y., Rackley R., Zhao X.L., Liefers G.J., Casey G., et al. Analysis of WT1 in granulosa cell and other sex cord-stromal tumors. Cancer Res 53 (1993) 2712-2714
18. Makrigiannakis A., Amin K., Coukos G., Tilly J.L., and Coutifaris C. Regulated expression and potential roles of p53 and Wilms' tumor suppressor gene (WT1) during follicular development in the human ovary. J Clin Endocrinol Metab 85 (2000) 449-459
19. King L.A., Okagaki T., Gallup D.G., Twiggs L.B., Messing M.J., and Carson L.F. Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. Gynecol Oncol 61 (1996) 227-232
20. Kotlar T., Young R.H., Albanese C., Crowley Jr. W.F., Scully R.E., and Jameson J.L. Absence of mutations in the FSH receptor in ovarian granulosa cell tumors. J Clin Endocrinol Metab 83 (1998) 3001
21. Giacaglia L.R., Kohek M.B.d.F., Carvalho F.M., Fragoso M.C., Mendonca B., and Latronico A.C. No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors. Fertil Steril 74 (2000) 992-995
22. Kalfa N., Ecochard A., Patte C., Duvillard P., Audran F., Pienkowski C., et al. Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor?. J Clin Endocrinol Metab 91 (2006) 1842-1847
23. Fuller P.J., and Chu S. Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours. Trends Endocrinol Metab 15 (2004) 122-128
24. Crisponi L., Deiana M., Loi A., Chiappe F., Uda M., Amati P., et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27 (2001) 159-166
25. Loffler K.A., Zarkower D., and Koopman P. Etiology of ovarian failure in blepharophimosis ptosis epicanthus inversus syndrome: FOXL2 is a conserved, early-acting gene in vertebrate ovarian development. Endocrinology 144 (2003) 3237-3243
26. Pannetier M., Servel N., Cocquet J., Besnard N., Cotinot C., and Pailhoux E. Expression studies of the PIS-regulated genes suggest different mechanisms of sex determination within mammals. Cytogenet Genome Res 101 (2003) 199-205
27. Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S., Rauscher III F.J., Emanuel B.S., et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 5 (1993) 230-235
28. Sorensen P.H., Lynch J.C., Qualman S.J., Tirabosco R., Lim J.F., Maurer H.M., et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol 20 (2002) 2672-2679
29. Hillion J., Le Coniat M., Jonveaux P., Berger R., and Bernard O.A. AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood 90 (1997) 3714-3719
30. Parry P., Wei Y., and Evans G. Cloning and characterization of the t(X;11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family. Genes Chromosomes Cancer 11 (1994) 79-84
31. Lin L., Miller C.T., Contreras J.I., Prescott M.S., Dagenais S.L., Wu R., et al. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res 62 (2002) 5273-5279
32. Li J., and Vogt P.K. The retroviral oncogene qin belongs to the transcription factor family that includes the homeotic gene fork head. Proc Natl Acad Sci U S A 90 (1993) 4490-4494
33. Nakamura T., Furukawa Y., Nakagawa H., Tsunoda T., Ohigashi H., Murata K., et al. Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 23 (2004) 2385-2400
34. Teh M.T., Wong S.T., Neill G.W., Ghali L.R., Philpott M.P., and Quinn A.G. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 62 (2002) 4773-4780
35. Katoh M. Human FOX gene family (Review). Int J Oncol 25 (2004) 1495-1500
36. Lee K., Pisarska M.D., Ko J.J., Kang Y., Yoon S., Ryou S.M., et al. Transcriptional factor FOXL2 interacts with DP103 and induces apoptosis. Biochem Biophys Res Commun 336 (2005) 876-881
37. Meredith S., Dudenhoeffer G., and Jackson K. Classification of small type B/C follicles as primordial follicles in mature rats. J Reprod Fertil 119 (2000) 43-48
38. Cocquet J., Pannetier M., Fellous M., and Veitia R.A. Sense and antisense Foxl2 transcripts in mouse. Genomics 85 (2005) 531-541